PLASMA-CONCENTRATIONS OF BETAMETHASONE AFTER TOPICAL APPLICATION OF BETAMETHASONE 17-VALERATE - COMPARISON WITH ORAL-ADMINISTRATION

被引:11
|
作者
KUBOTA, K
LO, ES
HUTTINOT, G
ANDERSEN, PH
MAIBACH, HI
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT DERMATOL,SURGE 110,BOX 0989,SAN FRANCISCO,CA 94143
[2] NEW YORK STATE PSYCHIAT INST & HOSP,ANALYT PSYCHOPHARMACOL LABS,NEW YORK,NY 10032
关键词
CORTICOSTEROID; BETAMETHASONE; 17-VALERATE; PERCUTANEOUS ABSORPTION; PHARMACOKINETICS;
D O I
10.1111/j.1365-2125.1994.tb04246.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Plasma concentrations of betamethasone were measured by r.i.a. after oral administration of 0.6 mg betamethasone and topical application of betamethasone 17-valerate in the same five healthy subjects. Betamethasone 17-valerate was prepared as a suspension in medical grade pressure sensitive adhesive and applied to a 100 cm2 area on the back for 28 h. Mean maximum plasma concentrations were 5.0 and 0.24 ng ml-1 and mean AUC values were 75.4 and 7.74 ng ml-1 h after oral and topical administrations, respectively. The mean plasma elimination half-life of betamethasone after the removal of topical betamethasone 17-valerate was 16.6 h which was twice that after oral administration, 8.1 h. Betamethasone 17-valerate may require application to the skin more than twice daily.
引用
收藏
页码:86 / 88
页数:3
相关论文
共 50 条